ADH1C

From WikiMD's WELLNESSPEDIA

ADH1C is a gene that encodes the gamma subunit of the enzyme alcohol dehydrogenase, which is involved in the metabolic process of converting alcohols to aldehydes. This enzyme plays a crucial role in the metabolism of ethanol, a type of alcohol found in alcoholic beverages.

Structure[edit]

The ADH1C gene is located on chromosome 4q23 and is part of a cluster of alcohol dehydrogenase genes. The protein encoded by ADH1C is a subunit of the class I alcohol dehydrogenase enzyme, which is a dimeric enzyme composed of different subunit combinations, including alpha, beta, and gamma subunits. The gamma subunit encoded by ADH1C contributes to the enzyme's ability to oxidize ethanol to acetaldehyde.

Function[edit]

The primary function of the ADH1C-encoded enzyme is to catalyze the oxidation of ethanol to acetaldehyde, a reaction that is the first step in the metabolism of alcohol in the liver. This reaction is crucial for the detoxification of alcohol in the body. The enzyme also has activity towards other alcohols and is involved in the metabolism of retinol to retinal, which is important for vitamin A metabolism.

Genetic Variability[edit]

There are several polymorphisms in the ADH1C gene that affect the enzyme's activity and stability. These genetic variations can influence an individual's alcohol metabolism rate and susceptibility to alcohol-related diseases. For example, certain alleles of ADH1C are associated with faster ethanol metabolism, which can lead to higher levels of acetaldehyde, a toxic metabolite that contributes to the adverse effects of alcohol consumption.

Clinical Significance[edit]

Variations in the ADH1C gene have been studied in relation to alcohol use disorder, liver disease, and certain types of cancer. Individuals with certain ADH1C genotypes may have an increased risk of developing alcohol-related liver disease due to the accumulation of acetaldehyde. Additionally, the enzyme's role in retinol metabolism links it to conditions related to vitamin A deficiency.

Also see[edit]






Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.